ReviewFolia microbiologica2026
Detection and identification of pathogens using agents targeting the bacterial cell wall.
Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The widespread emergence of multidrug-resistant pathogenic bacteria across various environments, healthcare settings, and food industries, combined with the development of new methods to combat them, highlights the need for more precise, rapid, and cost-effective pathogen detection techniques. This is especially important for clinically relevant pathogens, as it allows treatment to begin as quickly as possible, enables more effective targeted therapies to be chosen, helps preserve the effectiveness of current antibacterial agents, and prevents infections from water- and foodborne bacterial pathogens. Currently, many methods can accurately identify bacteria at the species or strain level and determine their antibiotic resistance. However, most of these techniques require sample preparation and cell culture beforehand, which can be time-consuming and labor-intensive. This review aims to highlight approaches that focus on identifying bacterial cells-especially pathogenic groups-based on their surface properties. This includes agents such as antibodies, whole phage particles, phage receptor binding proteins, cell wall-binding domains of peptidoglycan hydrolases, and functionalized magnetic nanoparticles. These agents can bind to and recognize peptidoglycan, parts of it, and other cell wall components. Developing detection kits based on these agents could enable the rapid detection of pathogenic bacteria from genera such as Acinetobacter, Bacillus, Campylobacter, Clostridium, Enterococcus, Klebsiella, Listeria, Pseudomonas, Salmonella, Shigella, Staphylococcus, Streptococcus, Vibrio, and Yersinia. These methods also offer the potential to distinguish these infectious pathogens from each other and from bacteria of the natural microbiota. Detection typically takes from a few minutes to several hours, with a broad detection range depending on the pathogen species, the detecting agent, and the technique used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.